Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease

The efficacy of reduced intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT) for Ph+ acute lymphoblastic leukemia (ALL) is uncertain. We analyzed 197 adults with Ph+ ALL in first complete remission; 67 patients receiving RIC were matched with 130 receiving myeloablative c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachanova, Veronika, Marks, David I., Zhang, Mei-Jie, Wang, Hailin, de Lima, Marcos, Aljurf, Mahmoud D., Arellano, Martha, Artz, Andrew S., Bacher, Ulrike, Cahn, Jean-Yves, Chen, Yi-Bin, Copelan, Edward A., Drobyski, William R., Gale, Robert Peter, Greer, John P, Gupta, Vikas, Hale, Gregory A., Kebriaei, Partow, Lazarus, Hillard M., Lewis, Ian D., Lewis, Victor A., Liesveld, Jane L., Litzow, Mark R., Loren, Alison W., Miller, Alan M., Norkin, Maxim, Oran, Betul, Pidala, Joseph, Rowe, Jacob M., Savani, Bipin N., Saber, Wael, Vij, Ravi, Waller, Edmund K., Wiernik, Peter H., Weisdorf, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951192/
https://www.ncbi.nlm.nih.gov/pubmed/23989431
http://dx.doi.org/10.1038/leu.2013.253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951192/
https://www.ncbi.nlm.nih.gov/pubmed/23989431
http://dx.doi.org/10.1038/leu.2013.253

Ejemplares similares